₨ Official source-observed price
PKR 450.19
10's
PKR 45.02 / tablet
✓ Official DRAP price source observed · Source checked 2026-08-27
Price Intelligence
Equivalent price position
Same generic · strength · dosage form · compatible unitPrice Intelligence PRO →
This brandPKR 45.02/ tablet
Price position40% below medianvs like-for-like peer median
Peer comparators60current-price listings
🔒
MedInfoBase Pharma Pro
View Price Intelligence PRO
Unlock the full competitive price benchmark
See the exact peer median, min/max and quartiles, product rank, price percentile and the complete like-for-like competitor table.
Rank & percentilePeer medianFull competitor listPortfolio intelligence
Price-position comparison uses current official listed prices normalized to compatible units. It is a price benchmark, not a measure of sales, demand, prescription volume or market share.
Product details
- Generic
- Risperidone
- Therapeutic area
- CNS & mental health
- Drug class
- Antipsychotics
- ATC
- N05AX
- Strength
- 4 mg
- Dosage form
- Tablet
- Pack
- 10's
- Registration no.
- 093745
- Price record verified
- 2026-08-09
- Latest DRAP source check
- 2026-08-27 02:56
Manufacturer
Searle IV Solutions (Pvt) Ltd.
Explore this manufacturer's complete MedInfoBase portfolio, generics and current listed prices.
View company portfolio →Traceability
Official price history
| Amount | Effective from | Verified | Source | Status |
|---|---|---|---|---|
| PKR 450.19 | 2026-07-23 | 2026-08-09 | DRAP PharmaPrice Index | Current |
| PKR 222.01 | 2025-08-07 | 2026-08-08 | DRAP PharmaPrice Index | Historical |
Same generic
Other listed brands
Arsodon 3 mgArsons Pharmaceutical Industries (Pvt) Ltd · PKR 522.49Aryspride 2 mgArreta Pharmaceuticals (Pvt.) Ltd. · PKR 225.83Aryspride 4 mgArreta Pharmaceuticals (Pvt.) Ltd. · PKR 451.67Autiper 1 mgSearle IV Solutions (Pvt) Ltd. · PKR 126.20Autist 1 mgDanas Pharmaceuticals (Pvt) Ltd. · PKR 222.02Autist 4 mgDanas Pharmaceuticals (Pvt) Ltd. · PKR 721.53Autist 2 mgDanas Pharmaceuticals (Pvt) Ltd. · PKR 360.77Autist 3 mgDanas Pharmaceuticals (Pvt) Ltd. · PKR 555.02
Evidence note: “Source observed” means MedInfoBase captured the record from an official DRAP source; it does not by itself mean the product registration was independently matched in the DRAP registry. Price note: Unit-price comparisons are informational calculations from official-source pack prices and normalized pack quantities. A pharmacy's transaction price may differ. Verify current regulatory and product information before professional use.
Cite this record
Medicine record · DRAP registration 093745MedInfoBase. (2026). Autiper 4 mg Tablet (10's), Searle IV Solutions (Pvt) Ltd. — registration and price record [Data set]. MedInfoBase. Retrieved September 18, 2026, from https://medinfobase.com/brand/autiper-4-mg-093745-10s-searle-iv-solutions-pvt-ltd/ Data observed 9 August 2026. Source: DRAP PharmaPrice Index. DRAP registration 093745.
MedInfoBase. Autiper 4 mg Tablet (10's), Searle IV Solutions (Pvt) Ltd. — registration and price record [Internet]. Islamabad: MedInfoBase; 2026 [cited 2026 Sep 18]. Available from: https://medinfobase.com/brand/autiper-4-mg-093745-10s-searle-iv-solutions-pvt-ltd/ Data observed 9 August 2026. Source: DRAP PharmaPrice Index. DRAP registration 093745.
MedInfoBase (2026) Autiper 4 mg Tablet (10's), Searle IV Solutions (Pvt) Ltd. — registration and price record. Available at: https://medinfobase.com/brand/autiper-4-mg-093745-10s-searle-iv-solutions-pvt-ltd/ (Accessed: 18 September 2026).
"Autiper 4 mg Tablet (10's), Searle IV Solutions (Pvt) Ltd. — registration and price record." MedInfoBase, 2026, https://medinfobase.com/brand/autiper-4-mg-093745-10s-searle-iv-solutions-pvt-ltd/. Accessed 18 Sep 2026.
MedInfoBase. 2026. "Autiper 4 mg Tablet (10's), Searle IV Solutions (Pvt) Ltd. — registration and price record." Accessed September 18, 2026. https://medinfobase.com/brand/autiper-4-mg-093745-10s-searle-iv-solutions-pvt-ltd/.
Price and registration data on this page were observed on 9 August 2026. Records change over time, so please cite the observation date alongside the access date.